☐
|
Rule 13d-1(b)
|
☐
|
Rule 13d-1(c)
|
☒
|
Rule 13d-1(d)
|
CUSIP No. M96883109
|
13G/A
|
Page 2 of 7 Pages
|
1. |
NAMES OF REPORTING PERSONS
Aurum Ventures M.K.I. Ltd.
|
||
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ☐
(b) ☐
|
||
3. |
SEC USE ONLY
|
||
4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5. |
SOLE VOTING POWER
4,299,377
|
|
6. |
SHARED VOTING POWER
0
|
||
7. |
SOLE DISPOSITIVE POWER
4,299,377
|
||
8. |
SHARED DISPOSITIVE POWER
0
|
||
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,299,377
|
||
10. |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see
instructions)
☐
|
||
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.0% (1)
|
||
12. |
TYPE OF REPORTING PERSON (see instructions)
CO
|
(1)
|
Percentage is based on 35,881,128 Ordinary Shares of the Issuer that were issued and outstanding as of November 1, 2019, as set forth in the Issuer’s proxy statement, dated November 1, 2019, for its annual general meeting of shareholders
that took place (following initial adjournment due to lack of quorum) on December 30, 2019, which proxy statement was annexed as Exhibit 99.2 to the Report of Foreign Private Issuer on Form 6-K furnished by the Issuer to the SEC on November
1, 2019.
|
CUSIP No. M96883109
|
13G/A
|
Page 3 of 7 Pages
|
1. |
NAMES OF REPORTING PERSONS
Morris Kahn
|
||
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ☐
(b) ☐
|
||
3. |
SEC USE ONLY
|
||
4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5. |
SOLE VOTING POWER
0
|
|
6. |
SHARED VOTING POWER
4,299,377
|
||
7. |
SOLE DISPOSITIVE POWER
0
|
||
8. |
SHARED DISPOSITIVE POWER
4,299,377
|
||
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,299,377
|
||
10. |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see
instructions)
☐
|
||
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.0% (1)
|
||
12. |
TYPE OF REPORTING PERSON (see instructions)
IN
|
(1)
|
Percentage is based on 35,881,128 Ordinary Shares of the Issuer that were issued and outstanding as of November 1, 2019, as set forth in the Issuer’s proxy statement, dated November 1, 2019, for its annual general meeting of shareholders
that took place (following initial adjournment due to lack of quorum) on December 30, 2019, which proxy statement was annexed as Exhibit 99.2 to the Report of Foreign Private Issuer on Form 6-K furnished by the Issuer to the SEC on November
1, 2019.
|
(a)
|
Name of Issuer
Vascular Biogenics Ltd.
|
(b)
|
Address of Issuer’s Principal Executive Offices
8 HaSatat St. Modi’in, Israel 7178106
|
(a)
|
Name of Person Filing:
This Amendment No. 1 to the Statement of Beneficial Ownership on Schedule 13G that was filed on February 17, 2015 (this “Amendment”), is being filed by each of:
(i) Aurum Ventures M.K.I. Ltd. (the “Reporting Entity”) (ii) Morris Kahn (the “Reporting Individual”)
The Reporting Individual is the sole beneficial shareholder of the Reporting Entity. The Reporting Entity and the Reporting Individual are referred
to herein collectively as the “Reporting Persons”.
|
(b)
|
Address of Principal Business Office or, if None, Residence:
The principal business office of each of the Reporting Persons is c/o Aurum Group, 16 Abba Hillel Road
Ramat Gan 5250608, Israel
|
(c)
|
Citizenship:
The Reporting Entity is organized in Israel. The Reporting Individual is a citizen of the State of Israel.
|
(d)
|
Title of Class of Securities
Ordinary Shares, New Israeli Shekel (“NIS”) 0.01 par value
per share (“Ordinary Shares”)
|
(e)
|
CUSIP Number
M96883109
|
(a)
|
☐ |
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b)
|
☐ |
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c)
|
☐ |
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
(d)
|
☐ |
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e)
|
☐ |
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
(f)
|
☐ |
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
(g)
|
☐ |
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
(h)
|
☐ |
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
(i)
|
☐ |
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);
|
(j)
|
☐ |
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
|
(a)
|
Amount beneficially owned: 4,299,377 Ordinary Shares
|
(b)
|
Percent of
class: 12.0%.*
*Such percentage is based on 35,881,128 Ordinary Shares of the Issuer that were issued and outstanding as of November 1, 2019, as set forth in the
Issuer’s proxy statement, dated November 1, 2019, for its annual general meeting of shareholders that took place (following initial adjournment due to lack of quorum) on December 30, 2019, which proxy statement was annexed as Exhibit 99.2
to the Report of Foreign Private Issuer on Form 6-K furnished by the Issuer to the SEC on November 1, 2019.
|
|||
(c)
|
Number of shares as to which the person has:
|
|||
(i)
|
Sole power to vote or to direct the vote: Reporting Entity: 4,299,377
Reporting Individual: 0
|
|||
(ii)
|
Shared power to vote or to direct the vote: Reporting
Entity: 0
Reporting Individual: 4,299,377
|
|||
(iii)
|
Sole power to dispose or to direct the disposition of:
Reporting Entity: 4,299,377
Reporting Individual: 0
|
|||
(iv)
|
Shared power to dispose or to direct the disposition of:
Reporting Entity: 0
Reporting Individual:
4,299,377
|
AURUM VENTURES M.K.I. LTD.
By: /s/ Nir Dror-Darwish
Name:Nir Dror-Darwish
Title: Authorized Signatory
By: /s/ Ilan Lior
Name: Ilan Lior
Title: Authorized Signatory
Date: February 12, 2020
/s/ Morris Kahn
MORRIS KAHN
Date: February 12, 2020
|
AURUM
VENTURES M.K.I. LTD.
By: /s/ Nir Dror-Darwish
Name:Nir Dror-Darwish
Title: Authorized
Signatory
By: /s/ Ilan Lior
Name: Ilan
Lior
Title: Authorized
Signatory
Date: February
12, 2020
/s/ Morris Kahn
MORRIS
KAHN
Date: February
12, 2020
|